Story perspectives

AbbVie Invests $380M in New Facilities for Neuroscience

2/24/2026

Summary

Story summary

AbbVie Inc. will invest $380 million to build two active pharmaceutical ingredient facilities in North Chicago, Illinois, for neuroscience and obesity medicines.
Investment supports AbbVie's $100 billion commitment to U.S. research and development over the next decade.
Construction begins in 2026.
Construction is expected to be completed by 2029.
AbbVie will acquire a medical device facility in Arizona and invest in Massachusetts, with investments anticipated in 2026 to expand manufacturing.

1 of 1

Story summary

AbbVie Inc. will invest $380 million to build two active pharmaceutical ingredient facilities in North Chicago, Illinois, for neuroscience and obesity medicines.
Investment supports AbbVie's $100 billion commitment to U.S. research and development over the next decade.
Construction begins in 2026.
Construction is expected to be completed by 2029.
AbbVie will acquire a medical device facility in Arizona and invest in Massachusetts, with investments anticipated in 2026 to expand manufacturing.